ATE37358T1 - 1,3-disubstituierte piperidinverbindungen als neuroleptische mittel. - Google Patents

1,3-disubstituierte piperidinverbindungen als neuroleptische mittel.

Info

Publication number
ATE37358T1
ATE37358T1 AT85305079T AT85305079T ATE37358T1 AT E37358 T1 ATE37358 T1 AT E37358T1 AT 85305079 T AT85305079 T AT 85305079T AT 85305079 T AT85305079 T AT 85305079T AT E37358 T1 ATE37358 T1 AT E37358T1
Authority
AT
Austria
Prior art keywords
piperidine compounds
neuroleptic agents
useful
formula
fluoro
Prior art date
Application number
AT85305079T
Other languages
English (en)
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE37358T1 publication Critical patent/ATE37358T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT85305079T 1984-07-26 1985-07-17 1,3-disubstituierte piperidinverbindungen als neuroleptische mittel. ATE37358T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/634,910 US4593037A (en) 1984-07-26 1984-07-26 1,3-disubstituted piperidine compounds as neuroleptic agents
EP85305079A EP0175452B1 (de) 1984-07-26 1985-07-17 1,3-Disubstituierte Piperidinverbindungen als neuroleptische Mittel

Publications (1)

Publication Number Publication Date
ATE37358T1 true ATE37358T1 (de) 1988-10-15

Family

ID=24545655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85305079T ATE37358T1 (de) 1984-07-26 1985-07-17 1,3-disubstituierte piperidinverbindungen als neuroleptische mittel.

Country Status (8)

Country Link
US (1) US4593037A (de)
EP (1) EP0175452B1 (de)
JP (1) JPS6137768A (de)
AT (1) ATE37358T1 (de)
DE (1) DE3565102D1 (de)
DK (1) DK167974B1 (de)
GR (1) GR851811B (de)
IE (1) IE58121B1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299549A3 (de) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiäre 2,5-Dialkyl-3-phenyl-piperidin-Derivate mit Opiatantagonistischer Wirkung
WO1990006303A1 (en) * 1988-12-02 1990-06-14 Pfizer Inc. Arylpiperidine derivatives
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
US5459151A (en) * 1993-04-30 1995-10-17 American Home Products Corporation N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
US5457207A (en) * 1993-10-05 1995-10-10 Regents Of The University Of Minnesota Spirovesamicols
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB984119A (en) * 1960-06-20 1965-02-24 Aspro Nicholas Ltd Substituted piperidines and methods for their preparation
GB1044309A (en) * 1964-05-07 1966-09-28 Koninklijke Pharma Fab Nv Substituted 1-aralklyl-piperidines
FR2310762A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives n-substitues de la phenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4332942A (en) * 1977-09-13 1982-06-01 Pfizer, Inc. 3-(2-Hydroxy-4-(substituted)phenyl)azacycloalkanes as analgesics
EP0084920B1 (de) * 1979-12-05 1989-04-19 Per Arvid Emil Carlsson Verbindungen verwendbar als Zwischenprodukte oder Ausgangsstoffe zur Herstellung von therapeutisch verwendbaren Phenyl-azacycloalkanen

Also Published As

Publication number Publication date
EP0175452A1 (de) 1986-03-26
DK338985A (da) 1986-03-13
GR851811B (de) 1985-11-26
US4593037A (en) 1986-06-03
DK167974B1 (da) 1994-01-10
IE851857L (en) 1986-01-26
JPH0533696B2 (de) 1993-05-20
DE3565102D1 (en) 1988-10-27
IE58121B1 (en) 1993-07-14
EP0175452B1 (de) 1988-09-21
JPS6137768A (ja) 1986-02-22
DK338985D0 (da) 1985-07-25

Similar Documents

Publication Publication Date Title
KR900700486A (ko) 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법
ATE169001T1 (de) Substituierte spiro-azaringen als tachykinine rezeptor antagonisten
ATE65500T1 (de) Arylthioalkylphenylcarbonsaeuren, diese enthaltende zusammensetzungen und deren verwendung.
SE8804036L (sv) Ny anvaendning av 11,28-dioxa-4-azatricklo (22.3.1.04.9)-oktakos-18-en-derivat och farmaceutiska kompositioner innehaallande desamma
FR2692264B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
ATE147071T1 (de) 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung
PT77886B (fr) Naphtalene et azanaphtalenecarboxamide medicaments
ATE37358T1 (de) 1,3-disubstituierte piperidinverbindungen als neuroleptische mittel.
DE3855325D1 (de) Oxothiolane und Derivate, diese enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Arzneimittel
NO871059L (no) Nye carboxylsyrederivater, fremgangsmaate for fremstilling av disse, anvendelse derav, saa vel som legemidler inneholdende disse forbindelser.
ATE13297T1 (de) Piperidyliden-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
SE8503207D0 (sv) Pharmacologically active substituted benzamides
DK163287A (da) 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE62686T1 (de) Neue 3-oxadiazol- und 3-carbonsaeure-betacarbolinderivate, ihre herstellung und ihre verwendung als arzneimittel.
TR199902350T2 (xx) Yeni piridin t�revleri ve onlardan olu�an farmakotik bile�imler.
SE8500107D0 (sv) Neue 8alfa-acylaminoergoline
ATE244712T1 (de) Piperazino-derivative als neurokininantagonisten
ATE62908T1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
PE47596A1 (es) Derivado de quinoxalina util en terapia
DE68918402D1 (de) 1,2,3,4-Tetrahydro-1,9-Acridindiamine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
MX9204457A (es) Compuestos de 6-oxo-azepinoidol, asi como procedimientos y productos intermedios para su preparacion, y medicamentos que contienen estos compuestos.
MXPA03011193A (es) Nuevos compuestos utiles en enfermedad de reflujo.
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
FR2737207B1 (fr) Nouvelles n-heterocyclyl-1-aryloxyalcoyl-4-piperidinamines substituees, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee